{"nctId":"NCT00254501","briefTitle":"Empowering Patients to Better Manage Diabetes Through Self-Care","startDateStruct":{"date":"2005-11"},"conditions":["Type I or Type II Diabetes (Excludes Gestational Diabetes)"],"count":69,"armGroups":[{"label":"Usual Care plus out-of-pocket cost waiver","type":"ACTIVE_COMPARATOR","interventionNames":["Behavioral: Educational materials"]},{"label":"EMPOWER","type":"EXPERIMENTAL","interventionNames":["Behavioral: Pharmacist Counseling"]}],"interventions":[{"name":"Pharmacist Counseling","otherNames":[]},{"name":"Educational materials","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* diabetes (Type I or Type II)\n* enrolled in health plan with participating employer\n* age 18 or older\n* willing and able to provide informed consent\n\nExclusion Criteria:\n\n* gestational diabetes","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Hemoglobin A-1C From Baseline","description":"Compare changes in Hemoglobin A-1C from baseline between the two groups.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.16","spread":"0.42"},{"groupId":"OG001","value":"-0.50","spread":"0.50"}]}]}]},{"type":"SECONDARY","title":"Changes From Baseline in LDL, HDL, Total Cholesterol, Triglycerides","description":"Changes from baseline in LDL, HDL, total cholesterol, triglycerides.\n\nSample sizes for each individual test (usual care plus out-of-pocket cost waiver; EMPOWER group):\n\n1. LDL\n2. HDL\n3. Total cholesterol\n4. Triglycerides","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":null},{"groupId":"OG001","value":"-3.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.6","spread":null},{"groupId":"OG001","value":"-6.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.1","spread":null},{"groupId":"OG001","value":"-11.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.8","spread":null},{"groupId":"OG001","value":"-8.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Changes in Economic Outcomes (Total Cost of Care, Cost of Diabetes Medications, Cost of Diabetes Supplies) From Baseline to 12 Months","description":"Changes in claims-based economic data on costs of total health care, diabetes medications, and diabetes supplies from baseline to 12 months. Only participants who had a claim in the 12 months prior to baseline were included in these analyses. The resulting sample sizes (usual care plus out-of-pocket cost waiver; EMPOWER group) for these outcomes are:\n\n1. Total cost of care\n2. Costs of diabetes medications\n3. Costs of diabetes supplies","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-89","spread":null},{"groupId":"OG001","value":"1612","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"516","spread":null},{"groupId":"OG001","value":"450","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"237","spread":null},{"groupId":"OG001","value":"191","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Diabetes Knowledge and Empowerment (Patient Self-efficacy) From Baseline to 12 Months","description":"Psycho-social aspects of diabetes knowledge and empowerment. Sample sizes are in parentheses (usual care plus out-of-pocket cost waiver; EMPOWER group):\n\n1. Changes from baseline to 12 months for the Diabetes Empowerment Scale (DES). Mean score for 28 items each scored as a Likert scale from 1 to 5. Higher scores correspond to greater empowerment\n2. Changes from baseline to 12 months for the Adherence Starts with Knowledge (ASK-20) adherence barrier test total barrier score (TBC). The TBC has a range from 0 to 18 and higher scores correspond to greater barriers.\n3. Changes from baseline to 12 months for understanding of diabetes. This is a single question: \"How would you rate your understanding of diabetes and its treatment?\" which uses a 7-point scale Likert scale as the response from 1 (poor) to 7 (excellent).","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.29","spread":null},{"groupId":"OG001","value":"0.17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.25","spread":null},{"groupId":"OG001","value":"-0.65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.14","spread":null},{"groupId":"OG001","value":"0.54","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":31},"commonTop":[]}}}